Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection

About this update from Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A

Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP InspectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A